2. Academic Validation
  3. Recent advances in the management and understanding of macular degeneration

Recent advances in the management and understanding of macular degeneration

  • F1000Res. 2017 Apr 20;6:519. doi: 10.12688/f1000research.10998.1.
Sepehr Bahadorani 1,  Michael Singer 2
Affiliations

Affiliations

  • 1 University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • 2 Medical Center Ophthalmology Associates, San Antonio, TX, USA.
PMID: 28491291 DOI: 10.12688/f1000research.10998.1
Abstract

Current management of age-related macular degeneration (AMD) is directed at intravitreal injection of vascular endothelial growth factor (VEGF) inhibitors for the treatment of wet AMD and supplementation with oral antioxidants for the treatment of dry AMD. In this article, we will review recent clinical trials for the treatment of dry and wet AMD.

Keywords

lampalizumab; macular degeneration; stem cell.

Figures
Products